Literature DB >> 11403811

Association between atopic dermatitis and insulin-dependent diabetes mellitus: a case-control study.

A B Olesen1, S Juul, N Birkebaek, K Thestrup-Pedersen.   

Abstract

BACKGROUND: Up to two-thirds of children with atopic dermatitis have IgE-mediated allergic reactions and a Th2 immune reactivity pattern with low production of interferon gamma and high production of interleukin 4 after allergen stimulation of T lymphocytes. Insulin-dependent diabetes mellitus (IDDM) seems to be associated with a Th1 immune reactivity pattern. We therefore postulated that these diseases may be inversely associated.
METHODS: We designed a case-control study including 920 children with IDDM, registered in the Danish Registry for Childhood Diabetes, and a sample of 9732 non-diabetic children registered in the Danish Medical Birth Registry. The children were aged 3-15 years. Information on atopic dermatitis was obtained by questionnaires.
FINDINGS: The cumulative incidence of atopic dermatitis up to age 15 years was 13.1% among children with IDDM and 19.8% in non-diabetic children (p<0.0001). Among children who developed IDDM, the incidence of atopic dermatitis was significantly lower than in the controls before onset of IDDM (73 cases in 5314 person-months vs 1375 in 57432 person-months; odds ratio 0.49 [0.39-0.63]). After onset of IDDM, diabetic and non-diabetic groups did not differ in incidence of atopic dermatitis (1.36 [0.89-2.07]).
INTERPRETATION: Our findings may be explained by different acquired or inherited reactivity patterns associated with atopic dermatitis (Th2) and IDDM (Th1). The results do not allow us to find out whether early development of atopic dermatitis reduces the risk of IDDM, or a propensity for IDDM reduces the risk of early-onset atopic dermatitis.

Entities:  

Mesh:

Year:  2001        PMID: 11403811     DOI: 10.1016/S0140-6736(00)04896-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

1.  Combinations of common chronic paediatric diseases deviate the immune response in diverging directions.

Authors:  L Nilsson; A Kivling; M Jalmelid; K Fälth Magnusson; M Faresjö
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

2.  The Cross-Talk Between Atopic Dermatitis and Diabetes Mellitus: A Meta-Analysis.

Authors:  Hyder O Mirghani; Khalid Alhazmi; Salah Alghamdi; Mohammed Alraddadi
Journal:  Cureus       Date:  2021-03-07

3.  Type 1 diabetes and asthma: a systematic review and meta-analysis of observational studies.

Authors:  Rong Zeng; Zihan Wang; Jintao Zhang; Ziting Liang; Changjuan Xu; Jing Wang; Liang Dong
Journal:  Endocrine       Date:  2022-01-14       Impact factor: 3.633

4.  Prevention of diabetes in NOD mice by repeated exposures to a contact allergen inducing a sub-clinical dermatitis.

Authors:  Kaare Engkilde; Karsten Buschard; Axel Kornerup Hansen; Torkil Menné; Jeanne Duus Johansen
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

5.  Inverse relationship between allergic contact dermatitis and type 1 diabetes mellitus: a retrospective clinic-based study.

Authors:  K Engkilde; T Menné; J D Johansen
Journal:  Diabetologia       Date:  2006-02-21       Impact factor: 10.122

6.  Frequency of atopy and allergic disorders among adults with Type 1 diabetes mellitus in the southern Marmara region of Turkey.

Authors:  C Duran; D Ediger; C Ersoy; N F Coskun; H Selimoglu; I Ercan; S Kiyici; M Guclu; D A Saglam; E Erturk; E Tuncel; S Imamoglu
Journal:  J Endocrinol Invest       Date:  2008-03       Impact factor: 4.256

Review 7.  The nexus between atopic disease and autoimmunity: a review of the epidemiological and mechanistic literature.

Authors:  R L Rabin; A I Levinson
Journal:  Clin Exp Immunol       Date:  2008-05-26       Impact factor: 4.330

8.  Atopic eczema in early childhood could be protective against Type 1 diabetes.

Authors:  J Rosenbauer; P Herzig; G Giani
Journal:  Diabetologia       Date:  2003-06-11       Impact factor: 10.122

9.  A possible association between a dysfunctional skin barrier (filaggrin null-mutation status) and diabetes: a cross-sectional study.

Authors:  Jacob P Thyssen; Allan Linneberg; Berit C Carlsen; Jeanne D Johansen; Kåre Engkilde; Torben Hansen; Flemming Pociot; Oluf Pedersen; Michael Meldgaard; Pal B Szecsi; Steen Stender; Torkil Menné
Journal:  BMJ Open       Date:  2011-03-15       Impact factor: 2.692

10.  No association between loss-of-function mutations in filaggrin and diabetes, cardiovascular disease, and all-cause mortality.

Authors:  Lise Lotte N Husemoen; Tea Skaaby; Torben Jørgensen; Jacob P Thyssen; Michael Meldgaard; Pal B Szecsi; Steen Stender; Jeanne Duus Johansen; Allan Linneberg
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.